Masaru Miura
Overview
Explore the profile of Masaru Miura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1040
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamada H, Maeda J, Yoshida M, Koyama Y, Ohki H, Miura M, et al.
J Med Ultrason (2001)
. 2025 Feb;
PMID: 40009274
No abstract available.
2.
Iwasa T, Inuzuka R, Ono H, Sugitani Y, Yamazawa H, Hiraishi C, et al.
Circ J
. 2025 Jan;
PMID: 39814404
Background: Selexipag, an oral prostacyclin (PGI) receptor agonist, is approved for adult patients with pulmonary arterial hypertension (PAH). This study evaluated the efficacy and safety of selexipag for Japanese pediatric...
3.
Kasahara S, Yoshimura Y, Ichikawa H, Hirata Y, Murayama H, Nakano T, et al.
Ann Thorac Surg Short Rep
. 2025 Jan;
2(4):804-809.
PMID: 39790580
Background: We have developed a new hybrid warp-knit fabric for induction of in situ tissue regeneration that has shown appropriate antideterioration properties and expandability in preclinical studies. This study was...
4.
Yasuoka K, Gotoh Y, Taniguchi I, Nagano D, Nakamura K, Mizuno Y, et al.
Microbiol Immunol
. 2025 Jan;
69(3):182-190.
PMID: 39780644
Yersinia pseudotuberculosis (Ypt) is a gram-negative bacterium that infects both humans and animals primarily through fecal‒oral transmission. While Ypt causes acute gastroenteritis in humans, an association with Kawasaki disease (KD),...
5.
Nakanishi R, Nakamura T, Koyama Y, Akahoshi S, Hataya H, Miura M
Pediatr Cardiol
. 2024 Sep;
PMID: 39331124
Kawasaki disease (KD), an acute, febrile, self-limiting, multisystem vasculitis of unknown etiology, often involves the cardiac complications of coronary artery aneurysm development, myocarditis, pericarditis, and valvulitis. However, there are insufficient...
6.
Suganuma E, Miura M, Koyama Y, Kobayashi T, Kaneko T, Hokosaki T, et al.
Eur J Pediatr
. 2024 Sep;
183(11):4817-4825.
PMID: 39240388
Purpose: This study is to investigate whether angiotensin type 1 receptor blockers (ARBs) or angiotensin-converting enzyme inhibitors (ACEis) can regress coronary artery aneurysm (CAA) in patients with Kawasaki disease (KD)....
7.
Fukushima N, Maeda J, Yoshimura Y, Shibuya K, Nagamine H, Miura M
Pediatr Cardiol
. 2024 Aug;
PMID: 39134678
To investigate the relationship between quantitative tracheal geometry and clinical course among various types of vascular ring and to identify factors correlating with symptom presentation. Patients with vascular ring diagnosed...
8.
Miura M, Miyata K, Kaneko T, Akahoshi S, Morikawa Y, Matsushima T, et al.
Eur J Pediatr
. 2024 Jul;
183(10):4265-4274.
PMID: 39048743
The purpose of this study is to determine whether adding intravenous methylprednisolone pulse (IVMP) to primary adjunctive prednisolone with intravenous immunoglobulin (IVIG) improves treatment resistance and coronary artery aneurysms (CAA)...
9.
Hayashi H, Uda K, Araki Y, Akahoshi S, Tanaka M, Miyata K, et al.
Pediatr Infect Dis J
. 2023 Sep;
42(12):1041-1044.
PMID: 37725804
Background: Yersinia infection is known to present with Kawasaki disease (KD)-like symptoms although differentiating the 2 has been a challenge. The present study aimed to describe the clinical characteristics and...
10.
Miyazawa A, Matsushima T, Sakakibara H, Akahoshi S, Morikawa Y, Koyama Y, et al.
Pediatr Int
. 2023 Jul;
65(1):e15543.
PMID: 37493267
Background: Kawasaki disease (KD) presents with gallbladder enlargement (GBE) or hydrops in the acute phase. Although GBE is highly specific to KD, epidemiological data on GBE have not been updated....